Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Brii Bio to Receive $24 Million from Sale of Qpex; Gains Global License to Anti-Infective

publication date: Jun 26, 2023

Beijing Brii Bio will earn $24 million from the sale of Qpex, a San Diego anti-infectives company that is being acquired by Japan’s Shionogi Pharma for $100 million. As part of the deal, Brii agreed to make major changes to its in-licensing of three Qpex assets. The company will own global rights to BRII-693, a Qpex-discovered novel gram-negative anti-infective. Previously, it had Greater China rights. In return, Brii will transfer China rights to Shionogi for two other Qpex anti-infectives. Brii, an Opex shareholder, will receive the $24 million when the takeover deal is closed. More details....

Stock Symbol: (HK: 2137)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here